Neuronal Signaling Compound Li

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Neuronal Signaling Compound Library

MCE 国际站：Neuronal Signaling Compound Library

Neuronal Signaling is involved in the regulation of the mechanisms of the central nervous system (CNS) such as its structure, function, genetics and physiology as well as how this can be applied to understand diseases of the nervous system. Every information processing system in the CNS is composed of neurons and glia, neurons have evolved unique capabilities for intracellular signaling (communication within the cell) and intercellular signaling (communication between cells). G protein-coupled receptors (GPCRs), including 5-HT receptor, histamine receptor, opioid receptor, etc. are the largest class of sensory proteins and are important therapeutic targets in Neuronal Signaling. Besides, Notch signaling, such as β- and γ-secretase, also plays multiple roles in the development of the CNS including regulating neural stem cell (NSC) proliferation, survival, self-renewal and differentiation. GPCR dysfunction caused by receptor mutations and environmental challenges contributes to many neurological diseases. Notch signaling in neurons, glia, and NSCs is also involved in pathological changes that occur in disorders such as stroke, Alzheimer's disease and CNS tumors. Thus, targeting Neuronal Signaling, such as notch signaling and GPCRs, can be used as therapeutic interventions for several different CNS disorders.MCE designs a unique collection of 2381 Neuronal Signaling-related compounds that act as a useful tool for the research of neuronal regulation and neuronal diseases.

Description & Advantages:

•   A unique collection of 2381 Neuronal Signaling-related compounds for high throughput screening (HTS) and high content screening (HCS).

•   Targets such as 5-HT Receptor, AChE, Adrenergic Receptor, AMPAR, Beta-secretase, Dopamine Receptor, FAAH, Melatonin Receptor, AChR, Opioid Receptor, γ-secretase, etc.

•   A useful tool for the research of neuronal regulation and neuronal diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC₅₀, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.